Incline Therapeutics - Top 15 Biotech VC Deals of 2010

Company: Incline Therapeutics
Based: Redwood City, CA
Amount: $43M

Investors: Frazier Healthcare Ventures, 5AM Ventures, Technology Partners, Adams Street Partners, Saints Capital and Emergent Medical Partners

Scoop: In June, Incline closed a $43 million Series A funding round, as well as $3.5 million upfront for a potential buyout from Cadence Pharmaceuticals. The company, which is focusing on its needle-free pain med delivery device Ionsys, could be worth up to $228 million to Cadence--depending on when the deal goes through--plus another $57 million if Ionsys receives FDA approval.

Incline Therapeutics - Top 15 Biotech VC Deals of 2010

Suggested Articles

What a difference a day makes in biotech.

A report out this week by PwC thinks that biotech could be in for a good year for deals as it sees the momentum from 2019 growing.

A drug developed at Temple restores a mechanism in brain cells that prevents the toxic buildup of the proteins amyloid beta and tau in Alzheimer's.